These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 12118366

  • 1. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling.
    Ferrigno O, Lallemand F, Verrecchia F, L'Hoste S, Camonis J, Atfi A, Mauviel A.
    Oncogene; 2002 Jul 25; 21(32):4879-84. PubMed ID: 12118366
    [Abstract] [Full Text] [Related]

  • 2. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G, Komuro A, Goto K, Shinozaki M, Miyazawa K, Miyazono K, Imamura T.
    Biochem J; 2005 Mar 15; 386(Pt 3):461-70. PubMed ID: 15496141
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
    Hanyu A, Ishidou Y, Ebisawa T, Shimanuki T, Imamura T, Miyazono K.
    J Cell Biol; 2001 Dec 10; 155(6):1017-27. PubMed ID: 11739411
    [Abstract] [Full Text] [Related]

  • 5. STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling.
    Datta PK, Moses HL.
    Mol Cell Biol; 2000 May 10; 20(9):3157-67. PubMed ID: 10757800
    [Abstract] [Full Text] [Related]

  • 6. Crk-associated substrate lymphocyte type regulates transforming growth factor-beta signaling by inhibiting Smad6 and Smad7.
    Inamoto S, Iwata S, Inamoto T, Nomura S, Sasaki T, Urasaki Y, Hosono O, Kawasaki H, Tanaka H, Dang NH, Morimoto C.
    Oncogene; 2007 Feb 08; 26(6):893-904. PubMed ID: 16909115
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
    Itoh F, Asao H, Sugamura K, Heldin CH, ten Dijke P, Itoh S.
    EMBO J; 2001 Aug 01; 20(15):4132-42. PubMed ID: 11483516
    [Abstract] [Full Text] [Related]

  • 9. Phosphorylation regulation of the interaction between Smad7 and activin type I receptor.
    Liu X, Nagarajan RP, Vale W, Chen Y.
    FEBS Lett; 2002 May 22; 519(1-3):93-8. PubMed ID: 12023024
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
    Itoh S, Ericsson J, Nishikawa J, Heldin CH, ten Dijke P.
    Nucleic Acids Res; 2000 Nov 01; 28(21):4291-8. PubMed ID: 11058129
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).
    Komuro A, Imamura T, Saitoh M, Yoshida Y, Yamori T, Miyazono K, Miyazawa K.
    Oncogene; 2004 Sep 09; 23(41):6914-23. PubMed ID: 15221015
    [Abstract] [Full Text] [Related]

  • 14. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification.
    Sakou T, Onishi T, Yamamoto T, Nagamine T, Sampath Tk, Ten Dijke P.
    J Bone Miner Res; 1999 Jul 09; 14(7):1145-52. PubMed ID: 10404014
    [Abstract] [Full Text] [Related]

  • 15. AIP4 restricts transforming growth factor-beta signaling through a ubiquitination-independent mechanism.
    Lallemand F, Seo SR, Ferrand N, Pessah M, L'Hoste S, Rawadi G, Roman-Roman S, Camonis J, Atfi A.
    J Biol Chem; 2005 Jul 29; 280(30):27645-53. PubMed ID: 15946939
    [Abstract] [Full Text] [Related]

  • 16. Type I transforming growth factor beta receptor binds to and activates phosphatidylinositol 3-kinase.
    Yi JY, Shin I, Arteaga CL.
    J Biol Chem; 2005 Mar 18; 280(11):10870-6. PubMed ID: 15657037
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory smads and tgf-Beta signaling in glomerular cells.
    Schiffer M, Schiffer LE, Gupta A, Shaw AS, Roberts IS, Mundel P, Böttinger EP.
    J Am Soc Nephrol; 2002 Nov 18; 13(11):2657-66. PubMed ID: 12397035
    [Abstract] [Full Text] [Related]

  • 18. Yes-associated protein (YAP65) in relation to Smad7 expression in human pancreatic ductal adenocarcinoma.
    Guo J, Kleeff J, Zhao Y, Li J, Giese T, Esposito I, Büchler MW, Korc M, Friess H.
    Int J Mol Med; 2006 May 18; 17(5):761-7. PubMed ID: 16596258
    [Abstract] [Full Text] [Related]

  • 19. Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses.
    Itoh S, Thorikay M, Kowanetz M, Moustakas A, Itoh F, Heldin CH, ten Dijke P.
    J Biol Chem; 2003 Feb 07; 278(6):3751-61. PubMed ID: 12446693
    [Abstract] [Full Text] [Related]

  • 20. Transforming growth factor-beta induces formation of a dithiothreitol-resistant type I/Type II receptor complex in live cells.
    Wells RG, Gilboa L, Sun Y, Liu X, Henis YI, Lodish HF.
    J Biol Chem; 1999 Feb 26; 274(9):5716-22. PubMed ID: 10026191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.